Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,407 | 43,777 | 0 | 0 | 0 |
| Receivables | 109 | 109 | 0 | 0 | 0 |
| TOTAL | $42,103 | $44,429 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 270 | 0 | 0 | 0 | 0 |
| TOTAL | $270 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $42,373 | $44,429 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 918 | 531 | 0 | 0 | 0 |
| Accrued Expenses | 1,634 | 423 | 0 | 0 | 0 |
| TOTAL | $2,552 | $954 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 85,283 | 62,066 | 0 | 0 | 0 |
| TOTAL | $85,283 | $62,066 | $N/A | $N/A | $N/A |
| Total Liabilities | $87,835 | $63,020 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Retained earnings | -53,962 | -26,965 | 0 | 0 | 0 |
| TOTAL | $-45,462 | $-18,591 | $0 | $0 | $0 |
| Total Liabilities And Equity | $42,373 | $44,429 | $0 | $0 | $0 |